compare the therapeutic effect of periurethral injection of autologous platelet-rich plasma (PRP) and injectable platelet rich fibrin (i-PRF) in treatment of female stress urinary incontinence and comparing the need for re-injection in the two groups.
Study Type
INTERVENTIONAL
Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Enrollment
40
Approximately 5 mL of PRP will be injected at three points (on both sides of the urethra and urethrovaginal space) under local anesthesia. Injections will be performed by gynecologist in the outpatient clinic.
Approximately 5 mL of i-PRF will be injected at three points (on both sides of the urethra and urethrovaginal space) under local anesthesia. Injections will be performed by gynecologist in the outpatient clinic
Kafr Elsheikh University Hospital
Kafr ash Shaykh, Egypt
changes in the severity of SUI measured by Incontinence Impact Questionnaire (IIQ7)
Time frame: baseline and three and six months follow up
changes in the severity of SUI using 10 point visual analogue scale
Time frame: baseline and three and six months follow up
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.